APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long Read Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long Read Sequencing Market Analysis and Forecast 2026-2032

Report ID 17417940024 March 2026198 pages

Choose your research edition.

Industry ResearchLong Read Sequencing Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Long Read Sequencing Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Long Read Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long Read Sequencing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Long Read Sequencing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Long Read Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Long Read Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long Read Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long Read Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long Read Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Long Read Sequencing include Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics, Takara Bio and Quantapore, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Long Read Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long Read Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Long Read Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long Read Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long Read Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Long Read Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Long Read Sequencing Segment by Company

Oxford Nanopore Technologies

Pacific Biosciences of California

BaseClear B.V.

Future Genomics Technologies

Garvan Institute of Medical Research

Genome Transcriptome Facility of Bordeaux

NextOmics

Takara Bio

Quantapore

Roche

MicrobesNG

Institute of Integrative Biology of the Cell

Long Read Sequencing Segment by Type

Consumables

Instruments

Services

Long Read Sequencing Segment by Application

Academic Research

Clinical Research

Hospitals & Clinics

Pharma & Biotech Entities

Other

Long Read Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long Read Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long Read Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long Read Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Long Read Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Long Read Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long Read Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long Read Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Consumables Major Player Table 3. Instruments Major Player Table 4. Services Major Player Table 5. Global Long Read Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic Research Major Player Table 7. Clinical Research Major Player Table 8. Hospitals & Clinics Major Player Table 9. Pharma & Biotech Entities Major Player Table 10. Other Major Player Table 11. Long Read Sequencing Industry Trends Table 12. Long Read Sequencing Industry Drivers Table 13. Long Read Sequencing Industry Opportunities and Challenges Table 14. Long Read Sequencing Industry Restraints Table 15. Global Long Read Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Long Read Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Long Read Sequencing Market Share by Region (2021-2026) Table 18. Global Long Read Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Long Read Sequencing Market Share by Region (2027-2032) Table 20. Global Long Read Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Long Read Sequencing Revenue Market Share by Players (2021-2026) Table 22. Global Long Read Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Long Read Sequencing Key Players Headquarters & Area Served Table 24. Global Long Read Sequencing Players, Product Type & Application Table 25. Global Long Read Sequencing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Long Read Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Long Read Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Long Read Sequencing Revenue Market Share by Type (2021-2026) Table 32. Global Long Read Sequencing Revenue Market Share by Type (2027-2032) Table 33. Global Long Read Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Long Read Sequencing Revenue Market Share by Application (2021-2026) Table 37. Global Long Read Sequencing Revenue Market Share by Application (2027-2032) Table 38. Oxford Nanopore Technologies Company Information Table 39. Oxford Nanopore Technologies Business Overview Table 40. Oxford Nanopore Technologies Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Oxford Nanopore Technologies Long Read Sequencing Product Portfolio Table 42. Oxford Nanopore Technologies Recent Development Table 43. Pacific Biosciences of California Company Information Table 44. Pacific Biosciences of California Business Overview Table 45. Pacific Biosciences of California Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Pacific Biosciences of California Long Read Sequencing Product Portfolio Table 47. Pacific Biosciences of California Recent Development Table 48. BaseClear B.V. Company Information Table 49. BaseClear B.V. Business Overview Table 50. BaseClear B.V. Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. BaseClear B.V. Long Read Sequencing Product Portfolio Table 52. BaseClear B.V. Recent Development Table 53. Future Genomics Technologies Company Information Table 54. Future Genomics Technologies Business Overview Table 55. Future Genomics Technologies Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Future Genomics Technologies Long Read Sequencing Product Portfolio Table 57. Future Genomics Technologies Recent Development Table 58. Garvan Institute of Medical Research Company Information Table 59. Garvan Institute of Medical Research Business Overview Table 60. Garvan Institute of Medical Research Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Garvan Institute of Medical Research Long Read Sequencing Product Portfolio Table 62. Garvan Institute of Medical Research Recent Development Table 63. Genome Transcriptome Facility of Bordeaux Company Information Table 64. Genome Transcriptome Facility of Bordeaux Business Overview Table 65. Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Portfolio Table 67. Genome Transcriptome Facility of Bordeaux Recent Development Table 68. NextOmics Company Information Table 69. NextOmics Business Overview Table 70. NextOmics Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. NextOmics Long Read Sequencing Product Portfolio Table 72. NextOmics Recent Development Table 73. Takara Bio Company Information Table 74. Takara Bio Business Overview Table 75. Takara Bio Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Takara Bio Long Read Sequencing Product Portfolio Table 77. Takara Bio Recent Development Table 78. Quantapore Company Information Table 79. Quantapore Business Overview Table 80. Quantapore Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Quantapore Long Read Sequencing Product Portfolio Table 82. Quantapore Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Long Read Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Roche Long Read Sequencing Product Portfolio Table 87. Roche Recent Development Table 88. MicrobesNG Company Information Table 89. MicrobesNG Business Overview Table 90. MicrobesNG Long Read Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. MicrobesNG Long Read Sequencing Product Portfolio Table 92. MicrobesNG Recent Development Table 93. Institute of Integrative Biology of the Cell Company Information Table 94. Institute of Integrative Biology of the Cell Business Overview Table 95. Institute of Integrative Biology of the Cell Long Read Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Institute of Integrative Biology of the Cell Long Read Sequencing Product Portfolio Table 97. Institute of Integrative Biology of the Cell Recent Development Table 98. North America Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Long Read Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 104. North America Long Read Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 105. Europe Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Long Read Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Long Read Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 112. China Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 113. China Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 114. China Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 115. China Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 117. Asia Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 118. Asia Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 119. Asia Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Long Read Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia Long Read Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 122. Asia Long Read Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 123. SAMEA Long Read Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 124. SAMEA Long Read Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 125. SAMEA Long Read Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 126. SAMEA Long Read Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 127. SAMEA Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. SAMEA Long Read Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 129. SAMEA Long Read Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Long Read Sequencing Image Figure 2. Global Long Read Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long Read Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Consumables Image Figure 5. Instruments Image Figure 6. Services Image Figure 7. Global Long Read Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Long Read Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic Research Image Figure 10. Clinical Research Image Figure 11. Hospitals & Clinics Image Figure 12. Pharma & Biotech Entities Image Figure 13. Other Image Figure 14. Global Long Read Sequencing Market Size (US$ Million) & (2021-2032) Figure 15. Global Long Read Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Long Read Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Long Read Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Long Read Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Long Read Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Long Read Sequencing Revenue Market Share by Type (2021-2032) Figure 22. Global Long Read Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Long Read Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Long Read Sequencing Revenue Market Share by Application (2021-2032) Figure 25. North America Long Read Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Long Read Sequencing Revenue Share by Type (2021-2032) Figure 27. North America Long Read Sequencing Revenue Share by Application (2021-2032) Figure 28. North America Long Read Sequencing Revenue Share by Country (2021-2032) Figure 29. United States Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Long Read Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Long Read Sequencing Revenue Share by Type (2021-2032) Figure 34. Europe Long Read Sequencing Revenue Share by Application (2021-2032) Figure 35. Europe Long Read Sequencing Revenue Share by Country (2021-2032) Figure 36. Germany Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Long Read Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Long Read Sequencing Revenue Share by Type (2021-2032) Figure 46. China Long Read Sequencing Revenue Share by Application (2021-2032) Figure 47. Asia Long Read Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Long Read Sequencing Revenue Share by Type (2021-2032) Figure 49. Asia Long Read Sequencing Revenue Share by Application (2021-2032) Figure 50. Asia Long Read Sequencing Revenue Share by Region (2021-2032) Figure 51. Japan Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Long Read Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Long Read Sequencing Revenue Share by Type (2021-2032) Figure 59. SAMEA Long Read Sequencing Revenue Share by Application (2021-2032) Figure 60. SAMEA Long Read Sequencing Revenue Share by Country (2021-2032) Figure 61. Brazil Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Long Read Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Consumables
  • Instruments
  • Services
Applications
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other
Companies covered
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California
  • BaseClear B.V.
  • Future Genomics Technologies
  • Garvan Institute of Medical Research
  • Genome Transcriptome Facility of Bordeaux
  • NextOmics
  • Takara Bio
  • Quantapore
  • Roche
  • MicrobesNG
  • Institute of Integrative Biology of the Cell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long Read Sequencing Market by Type
  3. 1.2.1 Global Long Read Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Consumables
  5. 1.2.3 Instruments
  6. 1.2.4 Services
  7. 1.3 Long Read Sequencing Market by Application
  8. 1.3.1 Global Long Read Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic Research
  10. 1.3.3 Clinical Research
  11. 1.3.4 Hospitals & Clinics
  12. 1.3.5 Pharma & Biotech Entities
  13. 1.3.6 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Long Read Sequencing Market Dynamics
  1. 2.1 Long Read Sequencing Industry Trends
  2. 2.2 Long Read Sequencing Industry Drivers
  3. 2.3 Long Read Sequencing Industry Opportunities and Challenges
  4. 2.4 Long Read Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Long Read Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Long Read Sequencing Growth Trends by Region
  3. 3.2.1 Global Long Read Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long Read Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Long Read Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Long Read Sequencing Revenue by Players
  2. 4.1.1 Global Long Read Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Long Read Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Long Read Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long Read Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Long Read Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Long Read Sequencing Players, Product Type & Application
  8. 4.5 Global Long Read Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Long Read Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Long Read Sequencing Tier 1, Tier 2, and Tier 3
5 Long Read Sequencing Market Size by Type
  1. 5.1 Global Long Read Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Long Read Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Long Read Sequencing Revenue Market Share by Type (2021-2032)
6 Long Read Sequencing Market Size by Application
  1. 6.1 Global Long Read Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Long Read Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Long Read Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Oxford Nanopore Technologies
  2. 7.1.1 Oxford Nanopore Technologies Company Information
  3. 7.1.2 Oxford Nanopore Technologies Business Overview
  4. 7.1.3 Oxford Nanopore Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Oxford Nanopore Technologies Long Read Sequencing Product Portfolio
  6. 7.1.5 Oxford Nanopore Technologies Recent Developments
  7. 7.2 Pacific Biosciences of California
  8. 7.2.1 Pacific Biosciences of California Company Information
  9. 7.2.2 Pacific Biosciences of California Business Overview
  10. 7.2.3 Pacific Biosciences of California Long Read Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pacific Biosciences of California Long Read Sequencing Product Portfolio
  12. 7.2.5 Pacific Biosciences of California Recent Developments
  13. 7.3 BaseClear B.V.
  14. 7.3.1 BaseClear B.V. Company Information
  15. 7.3.2 BaseClear B.V. Business Overview
  16. 7.3.3 BaseClear B.V. Long Read Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BaseClear B.V. Long Read Sequencing Product Portfolio
  18. 7.3.5 BaseClear B.V. Recent Developments
  19. 7.4 Future Genomics Technologies
  20. 7.4.1 Future Genomics Technologies Company Information
  21. 7.4.2 Future Genomics Technologies Business Overview
  22. 7.4.3 Future Genomics Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Future Genomics Technologies Long Read Sequencing Product Portfolio
  24. 7.4.5 Future Genomics Technologies Recent Developments
  25. 7.5 Garvan Institute of Medical Research
  26. 7.5.1 Garvan Institute of Medical Research Company Information
  27. 7.5.2 Garvan Institute of Medical Research Business Overview
  28. 7.5.3 Garvan Institute of Medical Research Long Read Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Garvan Institute of Medical Research Long Read Sequencing Product Portfolio
  30. 7.5.5 Garvan Institute of Medical Research Recent Developments
  31. 7.6 Genome Transcriptome Facility of Bordeaux
  32. 7.6.1 Genome Transcriptome Facility of Bordeaux Company Information
  33. 7.6.2 Genome Transcriptome Facility of Bordeaux Business Overview
  34. 7.6.3 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Portfolio
  36. 7.6.5 Genome Transcriptome Facility of Bordeaux Recent Developments
  37. 7.7 NextOmics
  38. 7.7.1 NextOmics Company Information
  39. 7.7.2 NextOmics Business Overview
  40. 7.7.3 NextOmics Long Read Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 NextOmics Long Read Sequencing Product Portfolio
  42. 7.7.5 NextOmics Recent Developments
  43. 7.8 Takara Bio
  44. 7.8.1 Takara Bio Company Information
  45. 7.8.2 Takara Bio Business Overview
  46. 7.8.3 Takara Bio Long Read Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Takara Bio Long Read Sequencing Product Portfolio
  48. 7.8.5 Takara Bio Recent Developments
  49. 7.9 Quantapore
  50. 7.9.1 Quantapore Company Information
  51. 7.9.2 Quantapore Business Overview
  52. 7.9.3 Quantapore Long Read Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Quantapore Long Read Sequencing Product Portfolio
  54. 7.9.5 Quantapore Recent Developments
  55. 7.10 Roche
  56. 7.10.1 Roche Company Information
  57. 7.10.2 Roche Business Overview
  58. 7.10.3 Roche Long Read Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Roche Long Read Sequencing Product Portfolio
  60. 7.10.5 Roche Recent Developments
  61. 7.11 MicrobesNG
  62. 7.11.1 MicrobesNG Company Information
  63. 7.11.2 MicrobesNG Business Overview
  64. 7.11.3 MicrobesNG Long Read Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MicrobesNG Long Read Sequencing Product Portfolio
  66. 7.11.5 MicrobesNG Recent Developments
  67. 7.12 Institute of Integrative Biology of the Cell
  68. 7.12.1 Institute of Integrative Biology of the Cell Company Information
  69. 7.12.2 Institute of Integrative Biology of the Cell Business Overview
  70. 7.12.3 Institute of Integrative Biology of the Cell Long Read Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Institute of Integrative Biology of the Cell Long Read Sequencing Product Portfolio
  72. 7.12.5 Institute of Integrative Biology of the Cell Recent Developments
8 North America
  1. 8.1 North America Long Read Sequencing Revenue (2021-2032)
  2. 8.2 North America Long Read Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Long Read Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Long Read Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Long Read Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Long Read Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Long Read Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Long Read Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Long Read Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Long Read Sequencing Revenue by Country
  11. 8.6.1 North America Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Long Read Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Long Read Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Long Read Sequencing Revenue (2021-2032)
  2. 9.2 Europe Long Read Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Long Read Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Long Read Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Long Read Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Long Read Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Long Read Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Long Read Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Long Read Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Long Read Sequencing Revenue by Country
  11. 9.6.1 Europe Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Long Read Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Long Read Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Long Read Sequencing Revenue (2021-2032)
  2. 10.2 China Long Read Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Long Read Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Long Read Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Long Read Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Long Read Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Long Read Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Long Read Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Long Read Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long Read Sequencing Revenue (2021-2032)
  2. 11.2 Asia Long Read Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Long Read Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Long Read Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Long Read Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Long Read Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Long Read Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Long Read Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Long Read Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Long Read Sequencing Revenue by Country
  11. 11.6.1 Asia Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Long Read Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Long Read Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long Read Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Long Read Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Long Read Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Long Read Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Long Read Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Long Read Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Long Read Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Long Read Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Long Read Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Long Read Sequencing Revenue by Country
  11. 12.6.1 SAMEA Long Read Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Long Read Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Long Read Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst